Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer

Use of ß-blockers and mortality following ovarian cancer diagnosis: a population-based cohort study

(2013) Sigrun A Johannesdottir et al.   BMC CANCER

β-blockers: a new role in cancer chemotherapy?

(2013) Archana S Nagaraja et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Impact of beta blocker medication in patients with platinum sensitive recurrent ovarian cancer—a combined analysis of 2 prospective multicenter trials by the AGO Study Group, NCIC-CTG and EORTC-GCG

(2013) Florian Heitz et al.   GYNECOLOGIC ONCOLOGY

β-Adrenergic system, a backstage manipulator regulating tumour progression and drug target in cancer therapy

(2013) Jing Tang et al.   SEMINARS IN CANCER BIOLOGY

Beta blocker use and ovarian cancer survival: A retrospective cohort study

(2012) R. Eskander et al.   GYNECOLOGIC ONCOLOGY

Impact of beta blockers on epithelial ovarian cancer survival

(2012) Elena S. Diaz et al.   GYNECOLOGIC ONCOLOGY

Beta-blockers may reduce intrusive thoughts in newly diagnosed cancer patients

(2012) Monica E. Lindgren et al.   PSYCHO-ONCOLOGY

The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer

(2010) E. K. Sloan et al.   CANCER RESEARCH

Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis

(2010) Anil K. Sood et al.   JOURNAL OF CLINICAL INVESTIGATION

Surgical Stress Promotes Tumor Growth in Ovarian Carcinoma

(2009) J.-W. Lee et al.   CLINICAL CANCER RESEARCH